Intralesional TTI-621, a novel biologic targeting the innate immune checkpoint CD47, in patients with relapsed or refractory mycosis fungoides or Sézary syndrome: a multicentre, phase 1 study
Titel:
Intralesional TTI-621, a novel biologic targeting the innate immune checkpoint CD47, in patients with relapsed or refractory mycosis fungoides or Sézary syndrome: a multicentre, phase 1 study
Auteur:
Querfeld, Christiane Thompson, John A Taylor, Matthew H DeSimone, Jennifer A Zain, Jasmine M Shustov, Andrei R Johns, Carolyn McCann, Sue Lin, Gloria H Y Petrova, Penka S Uger, Robert A Molloy, Naomi Shou, Yaping Akilov, Oleg E